Fairvalue-Calculator Fairvalue-Calculator
EN DE

genOway Société anonyme, a biotechnology company, (ALGEN) Fair Value & Analysis

Healthcare · FR · Market cap €29.5M

Price€2.40
Fair Value€1.52
Upside-36.7%
Quality95/100
Evidence: Medium Range €1.24 – €1.75

Fair value as of: Jun 24, 2026

Analysis

genOway Société anonyme, a biotechnology company, (ALGEN) currently trades at €2.40, while our model-based Fair Value estimate is €1.52 — implying the stock looks roughly 36.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is genOway Société anonyme, a biotechnology company, (ALGEN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €1.52 versus a price of €2.40 — about −37% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALGEN?
Our 21-model fair value for genOway Société anonyme, a biotechnology company, is €1.52 (as of Jun 24, 2026), built from audited fundamentals. The current price is €2.40.
What is the quality score of ALGEN?
genOway Société anonyme, a biotechnology company, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.